Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2016

Aug 18, 2016

31802_dirs_2016-08-18_4ac028b8-00d2-4a66-b760-7f60d59a2118.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2016-08-16

Reporting Person: Krell Elizabeth D (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-08-16 Common Stock M 8000 $2.58 Acquired 15162 Direct
2016-08-17 Common Stock S 5000 $15.20 Disposed 10162 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-08-16 Stock Option (right to buy) $2.58 M 8000 Disposed 2019-05-21 Common Stock (8000) Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $15.04 to $15.36 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: These options were granted on May 21, 2009 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant.